| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 15,196,745 | 16,087,281 | ||
| Accounts receivable, net | 10,430,602 | 10,316,911 | ||
| Inventories, net | 2,934,723 | 3,222,872 | ||
| Prepaid and other current assets | 1,377,378 | 1,578,265 | ||
| Total current assets | 29,939,448 | 31,205,329 | ||
| Non-current inventories | 9,183,862 | 9,526,122 | ||
| Property and equipment, net | 293,375 | 297,793 | ||
| Intangible assets, net | 15,010,795 | 15,988,232 | ||
| Goodwill | 914,000 | 914,000 | ||
| Operating lease right-of-use assets | 7,570,452 | 7,125,408 | ||
| Other assets | 2,986,628 | 2,850,265 | ||
| Total assets | 65,898,560 | 67,907,149 | ||
| Accounts payable | 13,832,497 | 13,446,531 | ||
| Operating lease current liabilities | 401,445 | 386,077 | ||
| Current portion of revolving line of credit | 0 | 0 | ||
| Other current liabilities | 10,076,027 | 10,139,532 | ||
| Total current liabilities | 24,309,969 | 23,972,140 | ||
| Revolving line of credit - long term | 5,240,733 | 5,240,733 | ||
| Operating lease non-current liabilities | 4,595,768 | 4,714,183 | ||
| Other long-term liabilities | 5,951,386 | 6,301,166 | ||
| Total liabilities | 40,097,856 | 40,228,222 | ||
| Common stock no par value 100,000,000 shares authorized 14,956,627 and 13,952,624 shares issued and outstanding as of september 30, 2025, and december 31, 2024, respectively | 51,512,221 | 51,441,398 | ||
| Accumulated deficit | -25,392,367 | -23,451,603 | ||
| Total shareholders equity | 26,119,854 | 27,989,795 | ||
| Noncontrolling interests | -319,150 | -310,868 | ||
| Total equity | 25,800,704 | 27,678,927 | ||
| Total liabilities and equity | 65,898,560 | 67,907,149 | ||
CUMBERLAND PHARMACEUTICALS INC (CPIX)
CUMBERLAND PHARMACEUTICALS INC (CPIX)